Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Learning to live with patency of the ductus arteriosus in preterm infants

Abstract

Treatment of persistent patency of the ductus arteriosus in preterm infants remains heterogeneous and controversial. Routine early treatment to induce ductal closure is not beneficial, but the potential criteria for, timing of, methods for and benefits of later ductal closure have not been determined. Management strategies for infants awaiting spontaneous closure or meeting criteria for treatment may be based on pathophysiological considerations but require evaluation in clinical trials. Better diagnostic tools allowing the identification of infants who might benefit from ductal closure, supplemented by data from clinical trials confirming realization of that potential, are urgently needed.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Medawar PB . Advice to a Young Scientist. Harper & Row: New York, 1979.

    Google Scholar 

  2. Benitz WE . Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol 2010; 30: 241–252.

    Article  CAS  PubMed  Google Scholar 

  3. Cooke L, Steer P, Woodgate P . Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2003; (2): CD003745.

  4. Fowlie PW, Davis PG . Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2002; (3): CD000174.

  5. Malviya M, Ohlsson A, Shah S . Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2008; (3): CD003951.

  6. Mosalli R, Alfaleh K . Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants. Cochrane Database Syst Rev 2008; (11): CD006181.

  7. Ohlsson A, Walia R, Shah SS . Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2010; (4): CD003481.

  8. Shah SS, Ohlsson A . Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006; (1): CD004213.

  9. Chorne N, Leonard C, Piecuch R, Clyman RI . Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics 2007; 119: 1165–1174.

    Article  PubMed  Google Scholar 

  10. Clyman R, Cassady G, Kirklin JK, Collins M, Philips III JB . The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial. J Pediatr 2009; 154: 873–876.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Gournay V, Roze JC, Kuster A, Daoud P, Cambonie G, Hascoet JM et al. Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 1939–1944.

    Article  CAS  PubMed  Google Scholar 

  12. Paquette L, Friedlich P, Ramanathan R, Seri I . Concurrent use of indomethacin and dexamethasone increases the risk of spontaneous intestinal perforation in very low birth weight neonates. J Perinatol 2006; 26: 486–492.

    Article  CAS  PubMed  Google Scholar 

  13. Ment LR, Vohr B, Allan W, Westerveld M, Sparrow SS, Schneider KC et al. Outcome of children in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics 2000; 105: 485–491.

    Article  CAS  PubMed  Google Scholar 

  14. Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001; 344: 1966–1972.

    Article  CAS  PubMed  Google Scholar 

  15. Rheinlaender C, Helfenstein D, Pees C, Walch E, Czernik C, Obladen M et al. Neurodevelopmental outcome after COX inhibitor treatment for patent ductus arteriosus. Early Hum Dev 2010; 86: 87–92.

    Article  CAS  PubMed  Google Scholar 

  16. Cassady G, Crouse DT, Kirklin JW, Strange MJ, Joiner CH, Godoy G et al. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N Engl J Med 1989; 320: 1511–1516.

    Article  CAS  PubMed  Google Scholar 

  17. Schmidt B, Roberts RS, Fanaroff A, Davis P, Kirpalani HM, Nwaesei C et al. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). J Pediatr 2006; 148: 730–734.

    Article  CAS  PubMed  Google Scholar 

  18. Yaseen H, al Umran K, Ali H, Rustum M, Darwich M, al-Faraidy A . Effects of early indomethacin administration on oxygenation and surfactant requirement in low birth weight infants. J Trop Pediatr 1997; 43: 42–46.

    Article  CAS  PubMed  Google Scholar 

  19. Van Overmeire B, Van de Broek H, Van Laer P, Weyler J, Vanhaesebrouck P . Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome. J Pediatr 2001; 138: 205–211.

    Article  CAS  PubMed  Google Scholar 

  20. Teixeira LS, Shivananda SP, Stephens D, Van Arsdell G, McNamara PJ . Postoperative cardiorespiratory instability following ligation of the preterm ductus arteriosus is related to early need for intervention. J Perinatol 2008; 28: 803–810.

    Article  CAS  PubMed  Google Scholar 

  21. Kabra NS, Schmidt B, Roberts RS, Doyle LW, Papile L, Fanaroff A . Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr 2007; 150: 229–234, 234 e221.

    Article  CAS  PubMed  Google Scholar 

  22. Clement WA, El-Hakim H, Phillipos EZ, Cote JJ . Unilateral vocal cord paralysis following patent ductus arteriosus ligation in extremely low-birth-weight infants. Arch Otolaryngol Head Neck Surg 2008; 134: 28–33.

    Article  PubMed  Google Scholar 

  23. Smith ME, King JD, Elsherif A, Muntz HR, Park AH, Kouretas PC . Should all newborns who undergo patent ductus arteriosus ligation be examined for vocal fold mobility? Laryngoscope 2009; 119: 1606–1609.

    Article  PubMed  Google Scholar 

  24. Mandhan P, Brown S, Kukkady A, Samarakkody U . Surgical closure of patent ductus arteriosus in preterm low birth weight infants. Congenit Heart Dis 2009; 4: 34–37.

    Article  PubMed  Google Scholar 

  25. Mandhan PL, Samarakkody U, Brown S, Kukkady A, Maoate K, Blakelock R et al. Comparison of suture ligation and clip application for the treatment of patent ductus arteriosus in preterm neonates. J Thorac Cardiovasc Surg 2006; 132: 672–674.

    Article  PubMed  Google Scholar 

  26. Lippmann M, Nelson RJ, Emmanouilides GC, Diskin J, Thibeault DW . Ligation of patent ductus arteriosus in premature infants. Br J Anaesth 1976; 48: 365–369.

    Article  CAS  PubMed  Google Scholar 

  27. Gould DS, Montenegro LM, Gaynor JW, Lacy SP, Ittenbach R, Stephens P et al. A comparison of on-site and off-site patent ductus arteriosus ligation in premature infants. Pediatrics 2003; 112: 1298–1301.

    Article  PubMed  Google Scholar 

  28. Shelton JE, Julian R, Walburgh E, Schneider E . Functional scoliosis as a long-term complication of surgical ligation for patent ductus arteriosus in premature infants. J Pediatr Surg 1986; 21: 855–857.

    Article  CAS  PubMed  Google Scholar 

  29. Fanos V, Benini D, Verlato G, Errico G, Cuzzolin L . Efficacy and renal tolerability of ibuprofen vs. indomethacin in preterm infants with patent ductus arteriosus. Fundam Clin Pharmacol 2005; 19: 187–193.

    Article  CAS  PubMed  Google Scholar 

  30. Shorter NA, Liu JY, Mooney DP, Harmon BJ . Indomethacin-associated bowel perforations: a study of possible risk factors. J Pediatr Surg 1999; 34: 442–444.

    Article  CAS  PubMed  Google Scholar 

  31. Watterberg KL, Gerdes JS, Cole CH, Aucott SW, Thilo EH, Mammel MC et al. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics 2004; 114: 1649–1657.

    Article  PubMed  Google Scholar 

  32. Van Bel F, Van de Bor M, Stijnen T, Baan J, Ruys JH . Cerebral blood flow velocity changes in preterm infants after a single dose of indomethacin: duration of its effect. Pediatrics 1989; 84: 802–807.

    CAS  PubMed  Google Scholar 

  33. Brown ER, Stark A, Sosenko I, Lawson EE, Avery ME . Bronchopulmonary dysplasia: possible relationship to pulmonary edema. J Pediatr 1978; 92: 982–984.

    Article  CAS  PubMed  Google Scholar 

  34. Pietz J, Achanti B, Lilien L, Stepka EC, Mehta SK . Prevention of necrotizing enterocolitis in preterm infants: a 20-year experience. Pediatrics 2007; 119: e164–e170.

    Article  PubMed  Google Scholar 

  35. Yoshimura T, Tsukimori K, Wake N, Nakano H . The influence of thermal environment on pulmonary hemodynamic acclimation to extrauterine life in normal full-term neonates. J Perinat Med 2007; 35: 236–240.

    Article  PubMed  Google Scholar 

  36. Carlo WA, Finer NN, Walsh MC, Rich W, Gantz MG, Laptook AR et al. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 2010; 362: 1959–1969.

    Article  CAS  PubMed  Google Scholar 

  37. Pansiot J, Loron G, Olivier P, Fontaine R, Charriaut-Marlangue C, Mercier JC et al. Neuroprotective effect of inhaled nitric oxide on excitotoxic-induced brain damage in neonatal rat. PLoS One 2010; 5: e10916.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Auten RL, Mason SN, Whorton MH, Lampe WR, Foster WM, Goldberg RN et al. Inhaled ethyl nitrite prevents hyperoxia-impaired postnatal alveolar development in newborn rats. Am J Respir Crit Care Med 2007; 176: 291–299.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Nihill MR, McNamara DG, Vick RL . The effects of increased blood viscosity on pulmonary vascular resistance. Am Heart J 1976; 92: 65–72.

    Article  CAS  PubMed  Google Scholar 

  40. Lister G, Hellenbrand WE, Kleinman CS, Talner NS . Physiologic effects of increasing hemoglobin concentration in left-to-right shunting in infants with ventricular septal defects. N Engl J Med 1982; 306: 502–506.

    Article  CAS  PubMed  Google Scholar 

  41. Bell EF, Strauss RG, Widness JA, Mahoney LT, Mock DM, Seward VJ et al. Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics 2005; 115: 1685–1691.

    Article  PubMed  Google Scholar 

  42. Chen H-L, Tseng H-I, Lu C-C, Yang S-N, Fan H-C, Yang R-C . Effect of blood transfusions on the outcome of very low body weight preterm infants under two different transfusion criteria. Pediatr Neonatol 2009; 50: 110–116.

    Article  PubMed  Google Scholar 

  43. Kavvadia V, Greenough A, Dimitriou G, Hooper R . Randomised trial of fluid restriction in ventilated very low birth weight infants. Arch Dis Child Fetal Neonatal Ed 2000; 83: F91–F96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 1998; 317: 235–240.

  45. Jardine LA, Jenkins-Manning S, Davies MW . Albumin infusion for low serum albumin in preterm newborn infants. Cochrane Database Syst Rev 2004; (3): CD004208.

  46. Gonzalez A, Sosenko IR, Chandar J, Hummler H, Claure N, Bancalari E . Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J Pediatr 1996; 128: 470–478.

    Article  CAS  PubMed  Google Scholar 

  47. Jobe AH, Ikegami M . Antenatal infection/inflammation and postnatal lung maturation and injury. Respir Res 2001; 2: 27–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. McCurnin D, Clyman RI . Effects of a patent ductus arteriosus on postprandial mesenteric perfusion in premature baboons. Pediatrics 2008; 122: e1262–e1267.

    Article  PubMed  Google Scholar 

  49. Chauhan M, Henderson G, McGuire W . Enteral feeding for very low birth weight infants: reducing the risk of necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed 2008; 93: F162–F166.

    Article  CAS  PubMed  Google Scholar 

  50. Berman Jr W, Dubynsky O, Whitman V, Friedman Z, Maisels MJ . Digoxin therapy in low-birth-weight infants with patent ductus arteriosus. J Pediatr 1978; 93: 652–655.

    Article  PubMed  Google Scholar 

  51. Lundell BP, Boreus LO . Digoxin therapy and left ventricular performance in premature infants with patent ductus arteriosus. Acta Paediatr Scand 1983; 72: 339–343.

    Article  CAS  PubMed  Google Scholar 

  52. Green TP, Thompson TR, Johnson DE, Lock JE . Furosemide promotes patent ductus arteriosus in premature infants with the respiratory-distress syndrome. N Engl J Med 1983; 308: 743–748.

    Article  CAS  PubMed  Google Scholar 

  53. Bell EF, Acarregui MJ . Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2008; (1): CD000503.

  54. Bell EF, Warburton D, Stonestreet BS, Oh W . Effect of fluid administration on the development of symptomatic patent ductus arteriosus and congestive heart failure in premature infants. N Engl J Med 1980; 302: 598–604.

    Article  CAS  PubMed  Google Scholar 

  55. Tammela OK, Lanning FP, Koivisto ME . The relationship of fluid restriction during the 1st month of life to the occurrence and severity of bronchopulmonary dysplasia in low birth weight infants: a 1-year radiological follow up. Eur J Pediatr 1992; 151: 367–371.

    Article  CAS  PubMed  Google Scholar 

  56. Reller MD, Buffkin DC, Colasurdo MA, Rice MJ, McDonald RW . Ductal patency in neonates with respiratory distress syndrome. A randomized surfactant trial. Am J Dis Child 1991; 145: 1017–1020.

    Article  CAS  PubMed  Google Scholar 

  57. Toyoshima K, Momma K, Nakanishi T . In vivo dilatation of the ductus arteriosus induced by furosemide in the rat. Pediatr Res 2010; 67: 173–176.

    Article  CAS  PubMed  Google Scholar 

  58. Vento M, Moro M, Escrig R, Arruza L, Villar G, Izquierdo I et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics 2009; 124: e439–e449.

    Article  PubMed  Google Scholar 

  59. Noori S, Patel D, Friedlich P, Siassi B, Seri I, Ramanathan R . Effects of low oxygen saturation limits on the ductus arteriosus in extremely low birth weight infants. J Perinatol 2009; 29: 553–557.

    Article  CAS  PubMed  Google Scholar 

  60. Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM . Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 2003; 349: 959–967.

    Article  CAS  PubMed  Google Scholar 

  61. Echtler K, Stark K, Lorenz M, Kerstan S, Walch A, Jennen L et al. Platelets contribute to postnatal occlusion of the ductus arteriosus. Nat Med 2010; 16: 75–82.

    Article  CAS  PubMed  Google Scholar 

  62. Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA . Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 2007; 115: 1634–1642.

    Article  PubMed  Google Scholar 

  63. Corazza MS, Davis RF, Merritt TA, Bejar R, Cvetnic W . Prolonged bleeding time in preterm infants receiving indomethacin for patent ductus arteriosus. J Pediatr 1984; 105: 292–296.

    Article  CAS  PubMed  Google Scholar 

  64. Norton ME, Merrill J, Cooper BA, Kuller JA, Clyman RI . Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993; 329: 1602–1607.

    Article  CAS  PubMed  Google Scholar 

  65. Hammerman C, Glaser J, Kaplan M, Schimmel MS, Ferber B, Eidelman AI . Indomethacin tocolysis increases postnatal patent ductus arteriosus severity. Pediatrics 1998; 102: E56.

    Article  CAS  PubMed  Google Scholar 

  66. Soraisham AS, Dalgleish S, Singhal N . Antenatal indomethacin tocolysis is associated with an increased need for surgical ligation of patent ductus arteriosus in preterm infants. J Obstet Gynaecol Can 2010; 32: 435–442.

    Article  PubMed  Google Scholar 

  67. Herrman K, Bose C, Lewis K, Laughon M . Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit. Arch Dis Child Fetal Neonatal Ed 2009; 94: F48–F50.

    Article  CAS  PubMed  Google Scholar 

  68. Sheffield MJ, Schmutz N, Lambert DK, Henry E, Christensen RD . Ibuprofen lysine administration to neonates with a patent ductus arteriosus: effect on platelet plug formation assessed by in vivo and in vitro measurements. J Perinatol 2009; 29: 39–43.

    Article  CAS  PubMed  Google Scholar 

  69. Vanhaesebrouck S, Zonnenberg I, Vandervoort P, Bruneel E, Van Hoestenberghe MR, Theyskens C . Conservative treatment for patent ductus arteriosus in the preterm. Arch Dis Child Fetal Neonatal Ed 2007; 92: F244–F247.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Jhaveri N, Moon-Grady A, Clyman RI . Early surgical ligation versus a conservative approach for management of patent ductus arteriosus that fails to close after indomethacin treatment. J Pediatr 2010; 157: 381–387 e381.

    Article  PubMed  PubMed Central  Google Scholar 

  71. McNamara PJ, Sehgal A . Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed 2007; 92: F424–F427.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Sehgal A, McNamara PJ . Does echocardiography facilitate determination of hemodynamic significance attributable to the ductus arteriosus? Eur J Pediatr 2009; 168: 907–914.

    Article  PubMed  Google Scholar 

  73. El-Khuffash A, Barry D, Walsh K, Davis PG, Molloy EJ . Biochemical markers may identify preterm infants with a patent ductus arteriosus at high risk of death or severe intraventricular haemorrhage. Arch Dis Child Fetal Neonatal Ed 2008; 93: F407–F412.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W E Benitz.

Ethics declarations

Competing interests

The author declares no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Benitz, W. Learning to live with patency of the ductus arteriosus in preterm infants. J Perinatol 31 (Suppl 1), S42–S48 (2011). https://doi.org/10.1038/jp.2010.175

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2010.175

Keywords

This article is cited by

Search

Quick links